Volv Global at ISPOR Global 2026, presenting new research in collaboration with Sanofi
Explore Volv Global’s ISPOR 2026 research with Sanofi on Pompe disease, based on use of machine learning-driven endpo...
Explore Volv Global’s ISPOR 2026 research with Sanofi on Pompe disease, based on use of machine learning-driven endpo...
AI-driven insights & RWD in Rare Disease: Accelerate AATD Diagnosis and identify undiagnosed AATD patients earlie...
Volv Global presented 2 posters at ATS 2025 showing work to assess how machine learning models can identify patients ...
A prediction model to identify symptomatic patients of different races and ethnicities with risk of Alpha-1 Antitryps...
Discover how Volv Global’s inTrigue AI helps identify rare disease patients earlier, improves diagnosis accuracy, and...
Case Study: Detecting signs of Fabry and Pompe disease in UK clinical data
